News ID: 280997
Published: 0352 GMT February 22, 2021

Iran’s COVID-19 vaccine 90% effective in initial human trials

Iran’s COVID-19 vaccine 90% effective in initial human trials

Iran’s CovIran Barekat, the country’s first domestically-developed COVID-19 vaccine, has shown 90-percent effectiveness, as confirmed by the first phase of human trials of the inoculation.

Mohammad Reza Salehi, who heads clinical trials for COVIran Barekat, said the results of immunogenicity tests on 35 people who volunteered to take part in the first phase of human trials of the vaccine were better than expected, Press TV reported.

“Preliminary results show that about 90 percent of the people who received two doses of the vaccine exhibit evidence of immunity,” he told IRNA, noting that more testing is needed for more precise results.

COVIran Barekat was named after the pharmaceutical group that developed it.

Last month, the head of the production team of the Iranian coronavirus vaccine at the Headquarters for Executing the Order of Imam Khomeini said COVIran Barekat also works against the variant of coronavirus that first emerged in the UK.

Iran launched human trials of the vaccine late December after successfully completing the initial steps, including tests on animals, and obtaining the necessary approvals.

By early this month, all 56 volunteers in the first phase of the vaccine’s human trials, had received both doses.

According to Salehi, the second phase of human trials is expected to start before the end of the current Iranian calendar year on March 20 and last through May.

Iranian scientists have been working on developing another domestic vaccine against the coronavirus, which is also in the human trial phase.

The second COVID-19 vaccine is a product of the Razi Vaccine and Serum Research Institute. Razi COV-Pars – an mRNA recombinant vaccine – is administered via injection and inhalation.

In parallel with efforts to develop homemade vaccines, Iran officially began the nationwide vaccination campaign against COVID-19 with the Russian Sputnik V vaccine earlier this month, delivering jabs to frontline health workers in the first phase.

Iran’s Health Minister Saeid Namaki said on Monday that 100,000 health workers will be vaccinated starting Tuesday as part of the second phase of the inoculation campaign.

He added that 250,000 vaccine doses developed by China will be delivered to Iran next week.

Iran’s Foreign Ministry spokesman Saeed Khatibzadeh said later that China had donated 250,000 doses of the Sinopharm vaccine to Iran.

Heath Ministry spokeswoman Sima Sadat Lari announced on Monday that the number of COVID-19 cases in Iran reached 1,582,275, with 8,263 new cases reported in a 24-hour period.

She added that 89 more patients died of the virus, bringing the total number of deaths to 59,572.



Security Key:
Captcha refresh
Page Generated in 1/0095 sec